Mona S. El‐Raziky

889 total citations
45 papers, 604 citations indexed

About

Mona S. El‐Raziky is a scholar working on Hepatology, Epidemiology and Hematology. According to data from OpenAlex, Mona S. El‐Raziky has authored 45 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 26 papers in Epidemiology and 8 papers in Hematology. Recurrent topics in Mona S. El‐Raziky's work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (19 papers) and Hepatitis B Virus Studies (15 papers). Mona S. El‐Raziky is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (19 papers) and Hepatitis B Virus Studies (15 papers). Mona S. El‐Raziky collaborates with scholars based in Egypt, United States and Saudi Arabia. Mona S. El‐Raziky's co-authors include Hanaa El‐Karaksy, Nehal El‐Koofy, Ghada M. Anwar, Fatma El‐Mougy, Hanaa El-Karaksy, Mortada El‐Shabrawi, Gamal Esmat, Magd A. Kotb, Nabil Mohsen and Olfat Shaker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and The Journal of Pediatrics.

In The Last Decade

Mona S. El‐Raziky

44 papers receiving 580 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mona S. El‐Raziky 353 299 75 60 60 45 604
Maria Grazia Marazzi 336 1.0× 295 1.0× 66 0.9× 96 1.6× 26 0.4× 29 801
Jörg Jahnel 435 1.2× 369 1.2× 280 3.7× 79 1.3× 64 1.1× 30 983
Nikolaos Papadopoulos 359 1.0× 255 0.9× 61 0.8× 37 0.6× 113 1.9× 45 618
Sadettin Hülagü 337 1.0× 142 0.5× 164 2.2× 20 0.3× 106 1.8× 42 670
И. Г. Бакулин 223 0.6× 136 0.5× 95 1.3× 78 1.3× 34 0.6× 124 472
Alina Grama 118 0.3× 106 0.4× 97 1.3× 18 0.3× 22 0.4× 46 437
E. Frauca 328 0.9× 422 1.4× 392 5.2× 37 0.6× 16 0.3× 55 843
Irena Jankowska 193 0.5× 240 0.8× 479 6.4× 15 0.3× 20 0.3× 107 903
P Garcia-Pont 649 1.8× 462 1.5× 41 0.5× 18 0.3× 111 1.9× 9 813
Raşit Vural Yağcı 276 0.8× 253 0.8× 230 3.1× 41 0.7× 8 0.1× 44 613

Countries citing papers authored by Mona S. El‐Raziky

Since Specialization
Citations

This map shows the geographic impact of Mona S. El‐Raziky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona S. El‐Raziky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona S. El‐Raziky more than expected).

Fields of papers citing papers by Mona S. El‐Raziky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona S. El‐Raziky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona S. El‐Raziky. The network helps show where Mona S. El‐Raziky may publish in the future.

Co-authorship network of co-authors of Mona S. El‐Raziky

This figure shows the co-authorship network connecting the top 25 collaborators of Mona S. El‐Raziky. A scholar is included among the top collaborators of Mona S. El‐Raziky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona S. El‐Raziky. Mona S. El‐Raziky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Raziky, Mona S., et al.. (2020). Secondary hepatic dysfunction in pediatric intensive care unit: Risk factors and outcome. Digestive and Liver Disease. 52(8). 889–894. 1 indexed citations
2.
El‐Raziky, Mona S., et al.. (2020). Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years. European Journal of Pediatrics. 179(5). 719–726. 4 indexed citations
3.
El‐Raziky, Mona S., et al.. (2019). Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection. Clinical Drug Investigation. 39(9). 857–864. 2 indexed citations
4.
El‐Karaksy, Hanaa, et al.. (2018). Focal hepatic lesions in Egyptian infants and children: the pediatric hepatologist perspective. Minerva Pediatrics. 70(1). 35–45. 2 indexed citations
5.
El‐Raziky, Mona S., et al.. (2016). Blind percutaneous liver biopsy in infants and children: Comparison of safety and efficacy of percussion technique and ultrasound assisted technique. Arab Journal of Gastroenterology. 17(4). 168–175. 6 indexed citations
6.
El‐Karaksy, Hanaa, et al.. (2015). Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children. Journal of Interferon & Cytokine Research. 36(1). 1–8. 13 indexed citations
7.
El-Karaksy, Hanaa, et al.. (2013). The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 9(2). 114–119. 15 indexed citations
8.
El‐Beshlawy, Amal, et al.. (2013). Intrafamilial Transmission of Hepatitis C Infection in Egyptian Multitransfused Thalassemia Patients. Journal of Tropical Pediatrics. 59(4). 309–313. 12 indexed citations
9.
El-Karaksy, Hanaa, et al.. (2013). Assessment of coagulation and fibrinolysis in children with chronic liver disease. Blood Coagulation & Fibrinolysis. 24(2). 113–117. 6 indexed citations
10.
El‐Raziky, Mona S., et al.. (2012). Patterns of hepatitis B infection in Egyptian children in the era of obligatory hepatitis B vaccination. Arab Journal of Gastroenterology. 13(1). 1–3. 10 indexed citations
11.
El‐Karaksy, Hanaa & Mona S. El‐Raziky. (2011). SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN. SHILAP Revista de lepidopterología. 3(1). e2011027–e2011027. 6 indexed citations
12.
Yosry, Ayman, et al.. (2011). The association of HLA class II DR B1 alleles with HCV infection in Egyptian children. Arab Journal of Gastroenterology. 12(1). 25–28. 4 indexed citations
13.
El‐Karaksy, Hanaa, et al.. (2011). A clinical study of Wilson’s disease: The experience of a single Egyptian Paediatric Hepatology Unit. Arab Journal of Gastroenterology. 12(3). 125–130. 11 indexed citations
14.
Anwar, Ghada M., et al.. (2011). Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children. Saudi Journal of Gastroenterology. 17(4). 265–265. 27 indexed citations
15.
El‐Raziky, Mona S., et al.. (2011). Relation of Serum Levels of Thrombopoietin to Thrombocytopenia in Extrahepatic Portal Vein Obstruction Versus Cirrhotic Children. Journal of Pediatric Hematology/Oncology. 33(7). e267–e270. 3 indexed citations
16.
El‐Raziky, Mona S., et al.. (2010). Impact of Giardia lamblia on Growth, Serum Levels of Zinc, Copper, and Iron in Egyptian Children. Biological Trace Element Research. 140(1). 1–6. 40 indexed citations
17.
Anwar, Ghada M., Mona S. El‐Raziky, Mohamed Hashem, et al.. (2010). Anti-HCV Prevalence among Diabetic and Non-Diabetic Egyptian Children. Current Diabetes Reviews. 6(6). 388–392. 12 indexed citations
18.
El‐Karaksy, Hanaa, et al.. (2007). Safety and efficacy of Rifampicin in children with cholestatic pruritus. The Indian Journal of Pediatrics. 74(3). 279–281. 6 indexed citations
19.
El‐Karaksy, Hanaa, Nehal El‐Koofy, Mortada El‐Shabrawi, et al.. (2004). Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Annals of Hematology. 84(3). 205–205. 1 indexed citations
20.
El‐Raziky, Mona S., Nehal El‐Koofy, Magd A. Kotb, et al.. (2004). Hepatitis C virus infection in Egyptian children: single centre experience. Journal of Viral Hepatitis. 11(5). 471–476. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Grazia Marazzi Breakdown of academic impact, for papers by Jörg Jahnel Breakdown of academic impact, for papers by Nikolaos Papadopoulos Breakdown of academic impact, for papers by Sadettin Hülagü Breakdown of academic impact, for papers by И. Г. Бакулин Breakdown of academic impact, for papers by Alina Grama Breakdown of academic impact, for papers by E. Frauca Breakdown of academic impact, for papers by Irena Jankowska Breakdown of academic impact, for papers by P Garcia-Pont Breakdown of academic impact, for papers by Raşit Vural Yağcı
Rankless by CCL
2026